Ahrens Brenton Karl
Insider CIK 1322927 · ACTV 10% owner · DRTX Director, 10% owner · ITRM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-12-23 | 2022-12-28 | 29,125 | $0.81 | $23.6K | 29,125 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-09-25 | 2022-09-28 | 14,838 | $1.59 | $23.6K | 14,838 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-09-20 | 2022-09-20 | 7,246 | $1.78 | $12.9K | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-09-19 | 2022-09-20 | 15,000 | $1.77 | $26.6K | 7,246 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-09-16 | 2022-09-20 | 15,000 | $1.90 | $28.5K | 22,246 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-09-15 | 2022-09-15 | 15,000 | $2.02 | $30.3K | 37,246 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-09-14 | 2022-09-15 | 15,000 | $2.10 | $31.5K | 52,246 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-09-13 | 2022-09-15 | 15,000 | $2.14 | $32.1K | 67,246 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-09-12 | 2022-09-12 | 15,000 | $2.31 | $34.6K | 82,246 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-09-09 | 2022-09-12 | 15,000 | $2.32 | $34.8K | 97,246 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2022-09-08 | 2022-09-12 | 3,298 | $2.26 | $7.5K | 112,246 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-06-25 | 2022-06-28 | 113,276 | — | $0 | 113,276 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-06-15 | 2022-06-17 | 647,059 | — | $0 | 647,059 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-03-25 | 2022-03-29 | 47,436 | — | $0 | 47,436 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-06-23 | 2021-06-25 | 64,706 | — | $0 | 64,706 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $2000000.00 | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2019-06-13 | 2019-06-17 | 19,671 | — | $0 | 19,671 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2019-05-24 | 2019-05-29 | 6,154 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2019-05-24 | 2019-05-29 | 6,154 | — | $0 | 6,154 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 229,660 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 721,408 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 275,446 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 721,408 | — | $0 | 721,408 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 275,446 | — | $0 | 996,854 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 229,660 | — | $0 | 1,226,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 506,656 | $13.00 | $6.59M | 1,733,170 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2018-05-24 | 2018-05-29 | 6,154 | — | $0 | 6,154 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-19 | 1,216 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-19 | 8,575 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | U Tender | 2014-11-17 | 2014-11-19 | 1,902,030 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-19 | 5,034 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | M Exercise deriv | 2014-08-26 | 2014-11-19 | 1,216 | — | $0 | 1,216 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | M Exercise deriv | 2014-08-26 | 2014-11-19 | 6,250 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | M Exercise | 2014-08-26 | 2014-11-19 | 5,034 | $2.08 | $10.5K | 5,034 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2014-05-21 | 2014-05-23 | 8,575 | — | $0 | 14,825 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion deriv | 2012-07-24 | 2012-07-26 | 10,771,804 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2012-07-24 | 2012-07-26 | 555,555 | $9.00 | $5.00M | 1,902,030 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion | 2012-07-24 | 2012-07-26 | 1,346,475 | — | $0 | 1,346,475 | SEC↗ |
| ACTV ACTIVE NETWORK INC | S Sale | 2012-03-05 | 2012-03-06 | 48,000 | $16.00 | $768.0K | 5,088,299 | SEC↗ |
| ACTV ACTIVE NETWORK INC | S Sale | 2012-03-02 | 2012-03-06 | 146,486 | $16.00 | $2.34M | 5,136,299 | SEC↗ |
| ACTV ACTIVE NETWORK INC | S Sale | 2012-03-01 | 2012-03-02 | 92,200 | $16.00 | $1.48M | 5,282,785 | SEC↗ |
| ACTV ACTIVE NETWORK INC | S Sale | 2012-02-29 | 2012-03-02 | 45,986 | $16.00 | $735.8K | 5,374,985 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2012-02-28 | 2012-07-26 | 6,250 | — | $0 | 6,250 | SEC↗ |
| ACTV ACTIVE NETWORK INC | S Sale | 2012-02-28 | 2012-02-29 | 62,300 | $16.00 | $996.8K | 5,420,971 | SEC↗ |
| ACTV ACTIVE NETWORK INC | S Sale | 2012-02-27 | 2012-02-29 | 78,400 | $15.85 | $1.24M | 5,483,271 | SEC↗ |